Overall rank by patents
#24,448
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 29 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A22C (PROCESSING MEAT, POULTRY, OR FISH).
The verdict
Hollymatic holds 11 US patents across 29 technology areas, rank #24,448 of 50,000 tracked assignees.
Hollymatic Corporation has been granted 11 US utility patents between 2016 and 2025, placing Hollymatic Corporation at rank #24,448 across all assignees tracked by PlainPatent. This portfolio spans 29 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.6 claims per patent with primary concentration in A22C (PROCESSING MEAT, POULTRY, OR FISH). As a US Corporation, Hollymatic Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Hollymatic sits between Hinova Pharmaceuticals Inc. (11 patents, rank #24,444) and Hsing CHAU Industrial Co., Ltd. (11 patents, rank #24,452) - the closest US assignees by grant volume. The composite Innovation Score of 49.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 3 in the 2015–2019 window, a +167% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Hollymatic Corporation's 13.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 29 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Hollymatic Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
HINOVA PHARMACEUTICALS INC.
11 patents
HISPANO SUIZA
11 patents
HITHIUM TECH HK LIMITED
11 patents
HOKUTO CORPORATION
11 patents
HOTECK INC.
11 patents
HOUGHTON TECHNICAL CORP.
11 patents
HP3 Real GmbH
11 patents
HSING CHAU INDUSTRIAL CO., LTD.
11 patents
HOLLYMATIC CORPORATION
11 patents
What this shows Hollymatic holds 11 patents at rank #24,448, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Hollymatic's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 15% higher than 85% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 27.3% |
| 2020 | 2 | 18.2% |
| 2022 | 1 | 9.1% |
| 2023 | 2 | 18.2% |
| 2024 | 1 | 9.1% |
| 2025 | 2 | 18.2% |
Top 15 of 29 technology areas
Overall rank by patents
#24,448
Across all tracked assignees
49.1 out of 100
How to use this portfolio
Hollymatic's 11 grants land it in the top 15% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.